TMCnet News

Global Pen Needles Market 2017-2021: High Cost of Pens Compared to Syringes is the Main Challenge - Research and Markets
[June 13, 2017]

Global Pen Needles Market 2017-2021: High Cost of Pens Compared to Syringes is the Main Challenge - Research and Markets


Research and Markets has announced the addition of the "Global Pen Needles Market 2017-2021" report to their offering.

The global pen needles market to grow at a CAGR of 10.06% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global pen needles market for 2017-2021. To calculate the market size, the report considers the revenue generated from sales of pen needle products. The report also includes a discussion of the Key vendors operating in this market.

The delivery of injectable medications into the body with pen devices are done with the help of pen needles. Advances in technology are causing a shift in end-user preference from invasive procedures to minimally and non-invasive procedures. Pen needles are mainly used by individuals with diabetes who require multiple daily injections.

Pens are preferred for drug delivery due to its user-friendliness and ease of use compared to syrings. The high cost of pens compared to syringes is the main challenge to the adoption of these devices. North American countries such as the US and Canada are the major revenue contributors due to the favorable reimbursement policies for pen needles.



Key vendors

  • BD
  • Novo Nordisk
  • Ypsomed
  • B. Braun

Other prominent vendors


  • Allison Medical
  • Artsana
  • Beipu Medicals
  • Henso Medical
  • HTL-STREFA
  • Medtronic
  • Medline
  • Menarini Diagnostics
  • Owen Mumford
  • Pietrasanta
  • Simple Diagnostics
  • Stat Medical
  • Terumo
  • Trividia Health
  • UltiMed

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by therapy

Part 08: Market segmentation by end-user

Part 09: Geographical segmentation

Part 10: Decision framework

Part 11: Drivers and challenges

Part 12: Market trends

Part 13: Vendor landscape

Part 14: Key vendor analysis

Part 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/z9zq3z/global_pen


[ Back To TMCnet.com's Homepage ]